Last deal

$4.38M
Local Amount - GBP 3.4M

Amount

Series A

Stage

25.07.2024

Date

3

all rounds

$6.43M

Total amount

date founded

Financing round

General

About Company
4Degra® is a company that uses a unique, patent-protected platform technology to 3D-print high resolution biodegradable medical devices.

Industry

Sector :

Subsector :

Keywords :

Also Known As

4D Medicine

founded date

01.10.2018

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company's precision 3D printable, biocompatible photo-polymer platform, 4Degra®, has highly tuneable mechanical properties that allow for the development of novel design solutions for resorbable medical device applications. By collaborating with medical device suppliers across a wide range of innovation projects, the company aims to transform patient experiences and outcomes over a wide range of indications ranging from drug delivery to reconstructive surgery. The company's patented range of novel polymeric 3-D printing resin-inks promises to meet all the requirements of an ideal biomaterial for use in regenerative medicine, including biocompatibility, non-toxic biodegradation, mechanical properties suited to the host tissue, and good handling properties in a clinical environment. The 3-D printable resin-inks will enable medical implants to be fitted to the exact shape and dimensional requirements of each patient, optimising outcomes in applications such as cancer treatment, degenerative spinal conditions and reconstructive surgery.
Contacts

Contact Email

Social url

Legal Names

Legal name

4D Medicine Ltd
Similar Companies
1000
Osfirm

Osfirm

Osperm is a biotechnology company that specializes in developing biocompatible medical devices, including biodegradable bones.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Medical Device, Biotechnology, Health Care

Location

Seongnam-si, Gyeonggi-do, South Korea

total rounds

3
Particle3D

Particle3D

Particle3D develops 3D-printed bone implants from natural materials.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, 3D Printing, Biotechnology

Location

Odense, Denmark

total rounds

4

total raised

$5.33M
NANOCHON

NANOCHON

Nanochon is a medical device company that uses 3D printing and nanomaterials to treat joint damages.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Usulutan, El Salvador

total rounds

8

total raised

$8.03M
POLTISS

POLTISS

Poltiss is a medical device company specialising in the development of photo-cured, adhesive polymer biomaterials.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Biotechnology, Medical Device, Health Care

Location

Szczecin, Poland

total rounds

1

total raised

$583.88K

Financials

Funding Rounds
5
3

Number of Funding Rounds

$6.43M

Money Raised

Their latest funding was raised on 25.07.2024. Their latest investor Boundary Capital Partners LLP. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
25.07.2024
3
$4.38M
Local Amount - GBP 3.4M
03.04.2024
1
$253.04K
Local Amount - GBP 200.01K
28.07.2021
4
$1.15M
Local Amount - GBP 1.6M
DSW Ventures

DSW Ventures

DSW Ventures invests in early-stage scale-up businesses requiring venture funding of more than £250,000.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Manchester, UK

count Of Investments

20
Co-Investors
Investors
6
3

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Pre-Seed, Seed
Boundary Capital Partners LLP

Boundary Capital Partners LLP

Boundary Capital Partners is a London-based VC firm investing in early stage tech companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Impact Investing

Location

London, UK

count Of Investments

23

count Of Exists

2
DSW Ventures

DSW Ventures

DSW Ventures invests in early-stage scale-up businesses requiring venture funding of more than £250,000.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Manchester, UK

count Of Investments

20
Ellie Boardman

Ellie Boardman

Eleanor Boardman, Investment Executive at DSW Ventures.

SFC Capital

SFC Capital

SFC Capital is a UK-based venture capital firm that provides capital and support to British startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance, Venture Capital

Location

London, UK

count Of Investments

595

count Of Exists

14

People

Founders
3
Philip Smith
Philip Smith

Philip Smith

With over 35 years’ experience in the engineering and materials industries and a track record of delivering fast business growth in a diverse range of start-ups, Phil is playing a key role in shaping 4D Medicine’s strategy and driving the business forward. Previous start-up roles include CEO at Interface Polymers, a polymer additive spin-out from the University of Warwick and Managing Director at a precision instrument spin-out from Cranfield University, majority owned by a FTSE 100 company. Between those appointments, Phil enjoyed a total of 12 years working as an independent consultant and a business development specialist with Warwick Ventures. Phil initially trained as an Engineering Technician in the aerospace instrumentation sector and became a Chartered Engineer in the late 90’s. Throughout his career, Phil has been excited by innovation and the satisfaction of working closely with customers to disrupt markets that are ready for change. Phil has an MBA (with distinction) from Warwick Business School, a BSc Hons in Materials Science and Technology from Brunel University and a Higher National Certificate in Mechanical and Production Engineering.

current job

4D Biomaterials
4D Biomaterials

organization founded

1

Philip Smith

Tim O'Connell
Tim O'Connell

Tim O'Connell

Tim O’Connell is our part-time Chief Financial Officer. A Chartered Accountant, who for 20 years held senior executive roles in the computer games industry seeing different facets of Publishing, Development and Distribution, thereby gaining experience in a wide range of operational disciplines. Tim helped grow companies including one group as FD from 10 employees to 300 and flotation and ultimate sale. He was responsible for opening a number of international offices/joint ventures and helped acquire/sell companies and close non-performing ones. Tim also gained considerable experience with legal contracts, commercial and corporate including IP. Since setting up a consultancy in 2003, Tim has helped mentor and develop business and strategic plans for a number of start-up and early growth companies, helping raise finance through equity, debt and grants. Tim also works with VC’s/Angels

current job

4D Biomaterials
4D Biomaterials

organization founded

1

Tim O'Connell

Andrew Dove
Andrew Dove

Andrew Dove

Professor Andrew Dove is a world-expert in degradable biomaterials/polymers at the School of Chemistry in the University of Birmingham. The creation of 4D Medicine Ltd was the culmination of over 12 years’ research and Andrew is determined to see his novel materials technology translated into a commercial success, delivering better treatment experiences and outcomes for medical patients across the globe. In his part-time role as a Director and CSO, Andrew continues to provide vital scientific guidance and support to the company. Andrew graduated from the University of York with an M.Chem. degree in 1999 and he gained his subsequent Ph.D. at Imperial College, London. Andrew undertook post-doctoral research at Stanford University, California and then as a post-doctoral fellow at IBM, San Jose, California. Andrew returned to the UK in 2006 and was appointed as an Assistant Professor at the University of Warwick, rising to Associate Professor in 2009 and Full Professor in 2014. In January 2018, Andrew joined the School of Chemistry at the University of Birmingham as Professor of Chemistry.

current job

4D Biomaterials
4D Biomaterials

organization founded

1

Andrew Dove

Employee Profiles
4
John Devine

John Devine

Non Executive Director

Tim O'Connell

Tim O'Connell

Chief Financial Officer

Andrew Dove

Andrew Dove

Founder and Chief Scientific Officer

Philip Smith

Philip Smith

Chief Executive Officer

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week